Our missions are: (i) to conduct policy-oriented research on a mechanism that will advance paths towards individualizing cancer therapeutics and diagnostics, especially for metastasized/ rare cancers; and (ii) to contribute to improving cancer/ science policy outcomes for public interests. Our focus is new social sciences. Our objective is not necessarily making policy recommendations. What we aim is to pursue logic and concepts that underlie features of events, which are relevant to policy questions.New social sciences encompass studies on science organizations, universities, transnationals, cancer/ science policies, care delivery system, institutions, intellectual property, among others.